Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
about
Von Willebrand disease: an overviewThe molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domainMolecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequencesEnhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdueVon Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.Desmopressin in the treatment of women's bleeding disorders.Audit of clinical management of von Willebrand disease during 1997 at a single institution and review of treatment patterns between 1980 and 1997.Comparison of two dimensional immunoelectrophoresis and multimer analysis in the study of von Willebrand factorvon Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).Von Willebrand factor and von Willebrand disease.Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptorsFunctional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to plateletsUpdate on inherited disorders of haemostasis and pregnancy.The molecular genetics of von Willebrand diseasePlasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study.Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.The diagnosis and treatment of von Willebrand disease in children.Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.Acquired hemostatic abnormalities in the elderly.Pregnancy complications and obstetric care in women with inherited bleeding disorders.von Willebrand disease and platelet disorders.Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.DDAVP in the treatment of bleeding disorders.Pathogenesis, clinical picture and treatment of von Willebrand's disease.Response to desmopressin in type IID von Willebrand's disease.Guidelines for the diagnosis and management of von Willebrand disease in Italy.When a patient with a bleeding disorder needs dental work. How you can work with the dentist to prevent a crisis.Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.Why and how do we classify von Willebrand disease?Diagnosis and management of von Willebrand disease.Classification of von Willebrand disease: emerging issues.Appendix II: A revised classification of Von Willebrand disease*: For The Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
P2860
Q28742241-06F5FAB8-610D-4C7F-BA2C-478A1D23EACEQ28776603-505CC2E3-6F13-4C22-99C4-3368DBB0AF71Q28776606-83B70564-7C92-4BDB-88E2-810002A4C325Q33442035-53CB2194-E0BC-455A-8EE1-BAFF62BB3305Q33442910-A7C219F0-B912-4F61-A514-E4367EBEC4C6Q33444536-B674AC2F-75C8-4227-9EF8-A7F96666ECDFQ33723752-FCF4614B-87A1-41E9-A944-0773253B8B5DQ33785738-64149EED-A302-4097-8A6B-2E727DC4F55BQ33838954-568740E7-1788-4F46-BAD0-267215BF7235Q33899746-F0D1E24B-758B-49DD-ABDA-4EB68CF4675CQ34029483-A8C1ABFB-9138-4607-BFF3-281B996B6BFAQ34528381-7757C2CF-9FEA-42CA-B71D-29BC94AEB68CQ34530389-8701E9FA-8791-459C-9AA3-63CF295F2665Q34726918-26A77AB9-1621-4AB3-8B87-20C27C0C7CD6Q35577294-9AEEFF1B-39D9-4F64-BF2E-B8EE47D03BCEQ36925330-0E80EFB4-8E87-4C76-BE5F-3BAE12329955Q37107274-A1230E9C-6EF5-4E8C-9703-4ACD2B55C27FQ37193881-83E69EA5-3A32-41CE-B0F2-4CCC78764B49Q37306950-F28CBE7F-09B9-41AC-B625-C75644821271Q37470139-4939D285-0CC6-4876-9B74-551CD77E01A2Q37479585-BB95222A-D751-404C-9057-0B82A82CBDFEQ37554183-0593A51C-7B1F-438B-9611-BF6CB8E71E70Q37671400-7EA0BAD2-0EF7-4C25-B525-3D332BF2AB15Q37941240-7698B89C-9DA4-46CE-8CEB-4579CA9E2D47Q38150467-36272DF1-3318-4811-8462-CD9BD086358EQ38206854-B3AC7637-40D9-4255-AF88-C22C8F616F03Q38953180-462CFAE7-D2AC-47B9-9AFA-0F65050EC6C1Q39511783-A1F95F4F-D231-4287-80DC-287D952594F0Q40999861-D1D7D2D0-5C2E-4411-9E43-7CD02839CB49Q44075866-B189AA19-F9F2-4126-AFDA-1F9AE2B0461EQ44117199-B25D6B3A-4B04-48B6-BAC9-E7476A4ABB43Q44580630-34DCCAA8-5A4A-425A-8763-48A03DBCC4E3Q45855717-B671C7F4-7A91-4D5C-928E-49494BEF210BQ45876135-08976B8A-559D-43A7-826B-1F8BFC579837Q45884955-094E190A-9EF2-449B-893A-B28F775B9BD7Q45884965-9B1593E3-7EEC-4D19-9AAD-2F01D67289F9Q45886373-8490A4A2-C5D4-42F2-AA32-4E9C154261E2
P2860
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
description
1983 nî lūn-bûn
@nan
1983 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@ast
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@en
type
label
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@ast
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@en
prefLabel
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@ast
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@en
P2093
P1476
Platelet aggregation induced b ...... IIB von Willebrand's disease.
@en
P2093
P304
P356
10.1056/NEJM198310063091402
P407
P577
1983-10-01T00:00:00Z